2023 Annual Meeting | S36 - Cerebrovascular Disease and Interventional Neurology: Basic and Translational Science

Date Wednesday 04/26/23

Time 01:00 PM - 03:00 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Wayne W. Feng, MD, FAAN, Andra L. Dingman, MD

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author.

CME Available 2.00 CME credits

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:12 PM EST	Speaker	2023 Michael S. Pessin Stroke Leadership Prize: This award recognizes emerging neurologists who have a strong interest in and have demonstrated a passion for learning and expanding the field of stroke research. Neal S. Parikh, MD
01:12 PM - 01:24 PM EST	Abstract	002 - Distinct imaging features of cerebral small vessel disease are related to rare NOTCH3 variants Zi-Yue Liu
01:24 PM - 01:36 PM EST	Abstract	003 - Patients with NOTCH2NLC GGC Repeat Expansion Presenting with Vascular Leukoencephalopathy Yi-Chu Liao, MD
01:36 PM - 01:48 PM EST	Abstract	004 - Association of serum glucose/potassium ratio with the prognosis of aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis Claudia Cruzalegui Bazán
01:48 PM - 02:00 PM EST	Abstract	005 - Abnormal Left Ventricular Geometry is Associated with Cerebral White Matter Disease Amr Salem, MBBCH
02:00 PM - 02:12 PM EST	Abstract	006 - Influence of Cortical Superficial Siderosis in Patients with Mixed Location Cerebral Microbleeds and Intracerebral Hemorrhage Alvin Das, MD
02:24 PM - 02:36 PM EST	Abstract	008 - A comprehensive framework for cerebral amyloid angiopathy diagnosis: Diagnostic accuracy meta-analyses of different biomarkers Antreas Charidimou, MD, PhD MSc
02:36 PM - 02:48 PM EST	Abstract	009 - Clinical Characteristics of Cerebral Amyloid Angiopathy and Risk Factors of Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage Juanjuan Wu, Other
02:48 PM - 03:00 PM EST	Abstract	010 - Protective Effect of APOE-e2 on Cortical Thickness and Volume in a Cerebrovascular Registry Hossam Youssef, MD

Faculty Disclosures
Xiaohong Huang	No disclosure on file
Lee H. Schwamm, MD, FAAN	Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime Education. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
W. T. Kimberly, MD, PhD	Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hyperfine Inc.. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Edip M. Gurol, MD	The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Nihas R. Mateti	Mr. Mateti has nothing to disclose.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Zheng-Yu Jin	No disclosure on file
Lixin Zhou	Lixin Zhou has nothing to disclose.
	No disclosure on file
Zi-Yue Liu	Zi-Yue Liu has nothing to disclose.
Avia Abramovitz	Ms. Abramovitz has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Anaiz D. Ticona Flores	Miss Ticona Flores has nothing to disclose.
Claudia Cruzalegui Bazán	Miss Cruzalegui Bazán has nothing to disclose.
Alvin Das, MD	Dr. Das has nothing to disclose.
Steven M. Greenberg, MD, PhD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Washington University/IQVIA. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Joshua Goldstein	Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Joshua Goldstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Portola. Joshua Goldstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ncontrol. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Joshua Goldstein has received stock or an ownership interest from NControl. The institution of Joshua Goldstein has received research support from Pfizer. The institution of Joshua Goldstein has received research support from Takeda.
Ming-Li Li	No disclosure on file
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Fei Han	No disclosure on file
Feifei Zhai	No disclosure on file
Bhrugun Anisetti, MBBS	Dr. Anisetti has nothing to disclose.
Jun Ni	No disclosure on file
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Liying Cui, PhD	No disclosure on file
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Jingyi Liu, MD	No disclosure on file
Antreas Charidimou, MD, PhD MSc	Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Journal of Neurological Sciences.
Amr Salem, MBBCH	Dr. Salem has nothing to disclose.
Ming Yao	No disclosure on file
Mei-jun Shu	Mei-jun Shu has nothing to disclose.
Hossam Youssef, MD	Mr. Youssef has nothing to disclose.
Juanjuan Wu, Other	Dr. Wu has nothing to disclose.
Renzo G. Vallejos	Mr. Vallejos has nothing to disclose.
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Yi-Chu Liao, MD	Dr. Liao has nothing to disclose.
Miguel F. Cabanillas Lazo	Mr. Cabanillas Lazo has nothing to disclose.
Milenka Del Rosario D. Cierto Torre	Miss Cierto Torre has nothing to disclose.
Yi-Chung Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Michelle P. Lin, MD	Dr. Lin has nothing to disclose.
Ahamed M. Elkhair, MD	Dr. Elkhair has nothing to disclose.
Erik Middlebrooks	No disclosure on file
Elif Gokcal	No disclosure on file
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for cases of neurological illness. Dr. Parikh has stock in Alnylam Pharmaceuticals. The institution of Dr. Parikh has received research support from Leon Levy Foundation. The institution of Dr. Parikh has received research support from Florence Gould Foundation. The institution of Dr. Parikh has received research support from NY State Empire Clinical Research Investigator Program. The institution of Dr. Parikh has received research support from NIA. The institution of Dr. Parikh has received research support from Medtronic.
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Andra L. Dingman, MD	Dr. Dingman has nothing to disclose.